← All trials
NCT05657990
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 20, 2023
- Primary completion
- Dec 31, 2026
- Completion date
- Dec 31, 2026
- First posted
- Dec 20, 2022
- Last posted
- Dec 22, 2022
- Enrollment
- 46
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Hackensack University Medical CenterLead sponsor
- Hackensack University Medical CenterOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.